Spectral signatures of colonic malignancies in the mid-infrared region: From basic research to clinical applicability

Future Oncology

Volumn 6, Issue 10, 2010, Pages 1653-1667

  Sahu, Ranjit K ^a,b   Mordechai, Shaul ^b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

colon cancer; crypt proliferation; Fourier transform infrared spectroscopy

Indexed keywords

CANCER DIAGNOSIS; CARCINOGENESIS; COLON CANCER; COLON MUCOSA; COLON POLYP; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; REVIEW;

ANIMALS; COLONIC NEOPLASMS; HUMANS; NEOPLASM STAGING; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 78149433458     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.10.120     Document Type: Review

References (72)

1. American Cancer Society: Cancer Facts and Figures. American Cancer Society, GA, USA (2009).
2. Eastwood GL: Gastrointestinal epithelial renewal. Gastroenterology 72, 962-975 (1977).
3. Lipkin M: Proliferation and differentiation of normal and diseased gastrointestinal cells. In: Physiology of the Gastrointestinal Tract (Second Edition). Johnson LR (Ed.). Raven Press, NY, USA, 255-284 (1987).
4. Wargovich MJ, Chen CD, Jimenez A et al.: Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol. Biomarkers Prev. 5, 355-360 (1996).
5. Deschner EE: Cell proliferation as a biological marker in human colorectal neoplasia. In: Colorectal Cancer: Prevention, Epidemiology and Screening. Winawer S, Schottenfeld D, Sherlock P (Eds). Raven Press, NY, USA (1980).
6. Moss SF, Liu TC, Petrotos A et al.: Inward growth of colonic adenomatous polyps. Gastroenterology 111, 1425-1432 (1996).
7. Yamashita N, Minamoto T, Onda M et al.: Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon. Jpn J. Cancer Res. 85, 692-698 (1994).
8. Keller JM, Cable S, El Bouhtoury F et al.: Peroxisome through cell differentiation and neoplasia. Biol. Cell 77, 77-88 (1993).
9. Anderson JC, Pleau DC, Rajan TV et al.: Increased frequency of serrated aberrant crypt foci among smokers. Am. J. Gastroenterol. 105(7), 1648-1654 (2010).
10. Mutch MG, Schoen RE, Fleshman JW et al.: A multicenter study of prevalence and risk factors for aberrant crypt foci. Clin. Gastroenterol. Hepatol. 5, 568-574 (2009).
11. Pinsky PF, Fleshman J, Mutch M et al.: One year recurrence of aberrant crypt foci. Cancer Prev. Res. (Phila.) 3(7), 839-843 (2010).
12. Ogata DC, Greca FH, Luz Mde A, Ioshii SO, Tomasich FD: Aberrant crypt foci and cancer of the colorectal junction: the correlation between ß-catenin/Ki-67 expression and the occurrence of early microscopic secondary lesions surrounding periphery colorectal cancer. Rev. Col. Bras. Cir. 37(2), 114-120 (2010).
13. Mutch MG, Mph RE, Fleshman JW et al.: A multi-center study of prevalence and risk factors for aberrant crypt foci. Clin. Gastroenterol. Hepatol. 7(5), 568-574 (2009).
14. Naumann D: FT-infrared and FT-Raman spectroscopy in biochemical research. In: Infrared and Raman Spectroscopy of Biological Materials. Gremlich H-U, Yan B (Eds). Practical Spectroscopy Series. Dekker Inc., NY, USA, 323-377 (2001).
15. Ellis DI, Goodacre R: Metabolic fngerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy. Analyst 131, 875-885 (2006).
16. Chiriboga L, Xie P, Yee H et al.: Infrared spectroscopy of human tissue. I. Differentiation and maturation of epithelial cells in the human cervix. Biospectroscopy 4, 47-53 (1998).
17. Salman A, Sahu RK, Bernshtain E et al.: Probing cell proliferation in the human colon using vibrational spectroscopy: a novel use of FTIR- microspectroscopy Vib. Spec. 4, 301-308 (2004).
18. Sahu RK, Argov S, Bernshtain E et al.: Detection of abnormal proliferation in histologically 'normal' colonic biopsies using FTIR-microspectroscopy Scand. J. Gastroenterology 39, 557-566 (2004).
19. Rigas B, Morgello S, Goldman IS, Wong PT: Human colorectal cancers display abnormal Fourier-transform infrared spectra. Proc. Natl Acad. Sci. USA 87(20), 8140-8144 (1990).
20. Rigas B, Wong PT: Human colon adenocarcinoma cell lines display infrared spectroscopic features of malignant colon tissues. Cancer Res. 52(1), 84-88 (1992).
21. Argov S, Ramesh J, Salman A et al.: Diagnostic potential of Fourier-transform infrared microspectroscopy and advanced computational methods in colon cancer patients. J. Biomed. Opt. 7, 248-254 (2002).
22. Wong PT, Senterman MK, Jackli P et al.: Detailed account of confounding factors in interpretation of FTIR spectra of exfoliated cervical cells. Biopolymers 67(6), 376-386 (2002).
23. Salman A, Argov S, Ramesh J et al.: FT-IR microscopic characterization of normal and malignant human colonic tissues. Cell. Mol. Biol. (Noisy-le-grand) 47, 159-166 (2001).
24. Sahu RK, Argov S, Salman A et al.: Can Fourier transform infrared spectroscopy at higher wave numbers (mid IR) shed light on biomarkers for carcinogenesis in tissues? J. Biomed. Opt. 10(5), 054017 (2005).
25. Gazi E, Dwyer J, Lockyer NP et al.: Fixation protocols for subcellular imaging by synchrotron-based Fourier transform infrared microspectroscopy. Biopolymers 77(1), 18-30 (2005).
26. Sahu RK, Argov S, Walfsch S, Bogomolny E, Moreh R, Mordechai S: Prediction potential of IR-micro spectroscopy for colon cancer relapse. Analyst 135(3), 538-544 (2010).
27. Lasch P, Naumann D: FT-IR microspectroscopic imaging of human carcinoma thin sections based on pattern recognition techniques. Cell. Mol. Biol. (Noisy-le-grand) 44(1), 189-202 (1998).
28. Lasch P, Haensch W, Naumann D, Diem M: Imaging of colorectal adenocarcinoma using FT-IR microspectroscopy and cluster analysis. Biochim. Biophys. Acta 1688(2), 176-186 (2004).
29. Sahu RK, Argov S, Salman A et al.: Characteristic absorbance of nucleic acids in the mid-IR region as possible common biomarkers for diagnosis of malignancy Technol. Cancer Res. Treat. 3(6), 629-638 (2004).
30. Mordechai S, Sahu RK, Hammody et al.: Possible common biomarkers from FTIR microspectroscopy of cervical cancer and melanoma. J. Microsc. 215(Pt 1), 86-91 (2004).
31. Gniadecka M, Philipsen PA, Sigurdsson S et al.: Melanoma diagnosis by Raman spectroscopy and neural networks: structure alterations in proteins and lipids in intact cancer tissue. J. Invest. Dermatol. 122(2), 443-449 (2004).
32. Zhang L, Small GW, Haka AS, Kidder LH, Lewis EN: Classifcation of Fourier transform infrared microscopic imaging data of human breast cells by cluster analysis and artifcial neural networks. Appl. Spectrosc. 57(1), 14-22 (2003).
33. Schultz CP: The potential role of Fourier transform infrared spectroscopy and imaging in cancer diagnosis incorporating complex mathematical methods. Technol. Cancer Res. Treat. 1(2), 95-104 (2002).
34. Mark S, Sahu RK, Kantarovich K et al.: Fourier transform infrared microspectroscopy as a quantitative diagnostic tool for assignment of premalignancy grading in cervical neoplasia. J. Biomed. Opt. 9(3), 558-567 (2004).
35. Podshyvalov A, Sahu RK, Mark S et al.: Distinction of cervical cancer biopsies by use of infrared microspectroscopy and probabilistic neural networks. Appl. Opt. 44(18), 3725-3734 (2005).
36. Argov S, Sahu RK, Bernshtain E et al.: Infammatory bowel diseases as an intermediate stage between normal and cancer: a FTIR-microspectroscopy approach. Biopolymers 75(5), 384-392 (2004).
37. Hammody Z, Huleihel M, Salman et al.: Potential of 'fat' f bre evanescent wave spectroscopy to discriminate between normal and malignant cells in vitro. J. Microsc. 228(Pt 2), 200-210 (2007).
38. Bogomolny E, Mordechai S, Zwielly A, Huleihel M: Early detection of premalignant changes in cell cultures using light-induced fuorescence spectroscopy. Eur. Biophys. J. 38(7), 971-980 (2009).
39. Chew SF Wood BR, Kanaan C et al.: Fourier transform infrared imaging as a method for detection of HLA class I expression in melanoma without the use of antibody. Tissue Antigens 69(Suppl. 1), 252-258 (2007).
40. Gazi E, Dwyer J, Lockyer N et al.: The combined application of FTIR microspectroscopy and ToF-SIMS imaging in the study of prostate cancer. Faraday Discuss. 126, 41-59; discussion 77-92 (2004).
41. Liu KZ, Schultz CP, Johnston JB et al.: Infrared spectroscopic study of bryostatin 1-induced membrane alterations in a B-CLL cell line. Leukemia 13(8), 1273-1280 (1999).
42. Takahashi S, Satomi A, Yano K et al.: Estimation of glycogen levels in human colorectal cancer tissue: relationship with cell cycle and tumor outgrowth. J. Gastroenterol. 34(4), 474-480 (1999).
43. Malins DC, Gilman NK, Green VM et al.: Metastatic cancer DNA phenotype identifed in normal tissues surrounding metastasizing prostate carcinomas. Proc. Natl Acad. Sci. USA 101(31), 11428-11431 (2004).
44. Malins DC, Anderson KM, Gilman NK, Green VM, Barker EA, Hellstrom KE: Development of a cancer DNA phenotype prior to tumor formation. Proc. Natl Acad. Sci. USA 101(29),10721-10725 (2004).
45. Malins DC, Johnson PM, Barker EA, Polissar NL, Wheeler TM, Anderson KM: Cancer-related changes in prostate DNA as men age and early identifcation of metastasis in primary prostate tumors. Proc. Natl Acad. Sci. USA 100(9), 5401-5406 (2003).
46. Malins DC, Polissar NL, Schaefer S, Su Y, Vinson M: A unifed theory of carcinogenesis based on order-disorder transitions in DNA structure as studied in the human ovary and breast. Proc. Natl Acad. Sci. USA 95(13), 7637-7642 (1998).
47. Li QB, Xu Z, Zhang NW et al.: In vivo and in situ detection of colorectal cancer using Fourier transform infrared spectroscopy World J. Gastroenterol. 11(3), 327-330 (2005).
48. Fujioka N, Morimoto Y, Arai T, Kikuchi M: Discrimination between normal and malignant human gastric tissues by Fourier transform infrared spectroscopy. Cancer Detect. Prev. 28(1), 32-36 (2004).
49. Wang JS, Shi JS, Xu YZ et al.: FT-IR spectroscopic analysis of normal and cancerous tissues of esophagus. World J. Gastroenterol. 9(9), 1897-1899 (2003).
50. Fukuyama Y, Yoshida S, Yanagisawa S, Shimizu M: A study on the differences between oral squamous cell carcinomas and normal oral mucosas measured by Fourier transform infrared spectroscopy Biospectroscopy 5(2), 117-126 (1999).
51. Gupta AK, Pinsky P, Rall C et al.: Reliability and accuracy of the endoscopic appearance in the identifcation of aberrant crypt foci. Gastrointest. Endosc. 70(2), 322-330 (2009).
52. Mackanos MA, Contag CH: Fiber-optic probes enable cancer detection with FTIR spectroscopy Trends Biotechnol. 28(6), 317-323 (2010).
53. Matsuura Y, Kino S, Yokoyama E, Katagiri T, Sato H, Tashiro H: Flexible fber-optics probes for Raman and FT-IR remote spectroscopy IEEE J. Selected Topics Quantum Electronics 13, 1704-1708 (2007).
54. Bindig U, Winter H, Wäsche W, Zelianeos K, Müller G: Fiber-optical and microscopic detection of malignant tissue by use of infrared spectrometry. J. Biomed. Opt. 7, 100-108 (2002).
55. Wu JG, Xu YZ, Sun CW et al.: Distinguishing malignant from normal oral tissues using FTIR fber-optic techniques. Biopolymers 62(4), 185-192 (2001).
56. Weng SF, Ling XF, Song YY et al.: FTIR fber optics and FT-Raman spectroscopic studies for the diagnosis of cancer. Am. Clin. Lab. 19(7), 20 (2000).
57. Krafft C, Kirsch M, Beleites C, Schackert G, Salzer R: Methodology for fber-optic Raman mapping and FTIR imaging of metastases in mouse brains. Anal. Bioanal. Chem. 389(4), 1133-1142 (2007).
58. Krafft C, Steiner G, Beleites C, Salzer R: Disease recognition by infrared and Raman spectroscopy. J. Biophotonics 2(1-2), 13-28 (2009).
59. Riley MR, Lucas P, Le Coq D et al.: Lung cell fber evanescent wave spectroscopic biosensing of inhalation health hazards. Biotechnol. Bioeng. 95(4), 599-612 (2006).
60. Lee J, Gazi E, Dwyer J et al.: Optical artefacts in transfection mode FTIR microspectroscopic images of single cells on a biological support: the effect of back-scattering into collection optics. Analyst 132(8), 750-755 (2007).
61. Bassan P, Byrne HJ, Lee J et al.: Refection contributions to the dispersion artefact in FTIR spectra of single biological cells. Analyst 134(6), 1171-1175 (2009).
62. Harvey TJ, Gazi E, Henderson A et al.: Factors infuencing the discrimination and classifcation of prostate cancer cell lines by FTIR microspectroscopy. Analyst 134(6), 1083-1091 (2009).
63. Bassan P, Kohler A, Martens H et al.: Resonant Mie scattering (RMieS) correction of infrared spectra from highly scattering biological samples. Analyst 135(2), 268-277 (2010).
64. Petibois C, Déléris G: Chemical mapping of tumor progression by FT-IR imaging: towards molecular histopathology Trends Biotechnol. 24, 455-462 (2006).
65. Levin IW, Bhargava R: Fourier transform infrared vibrational spectroscopic imaging: integrating microscopy and molecular recognition. Annu. Rev. Phys. Chem. 56, 429-474 (2005).
66. Kendall C, Isabelle M, Bazant-Hegemark F et al.: Vibrational spectroscopy: a clinical tool for cancer diagnostics. Analyst 134(6), 1029-1045 (2009).
67. Pijanka J, Sockalingum GD, Kohler A et al.: Synchrotron-based FTIR spectra of stained single cells. Towards a clinical application in pathology. Lab. Invest. 90(5), 797-807 (2010).
68. Das G, Nicastri A, Coluccio ML et al.: FT-IR, Raman, RRS measurements and DFT calculation for doxorubicin. Microsc. Res. Tech. 73(10), 991-995 (2010).
69. Mackanos MA, Contag CH: FTIR microspectroscopy for improved prostate cancer diagnosis. Trends Biotechnol. 27(12), 661-663 (2009).
70. Pijanka JK, Kohler A, Yang Y et al.: Spectroscopic signatures of single, isolated cancer cell nuclei using synchrotron infrared microscopy Analyst 134(6), 1176-1181 (2009).
71. Krafft C, Steiner G, Beleites C, Salzer R: Disease recognition by infrared and Raman spectroscopy J. Biophotonics 2(1-2), 13-28 (2009).
72. Zwielly A, Mordechai S, Sinielnikov I: Advanced statistical techniques applied to comprehensive FTIR spectra on human colonic tissues. Medical Phys. 37(3), 1-10 (2010).